Smart Nanocarriers for Targeted Cancer Therapy

Area of Science:

• Oncology
• Nanomedicine
• Biomaterials Science

Background:

• Cancer remains a significant global health threat, often incurable due to metastasis, multidrug resistance, and lack of targeted drug delivery.
• Conventional cancer treatments face limitations in efficacy and specificity.
• Nanomedicine has emerged as a promising field, leveraging nanomaterials' unique properties for therapeutic advancements.

Purpose of the Study:

• To review natural and synthetic nanocarriers engineered for active targeting of cancer cells.
• To highlight the advantages of nanocarriers over conventional cancer treatments.
• To discuss recent innovations in biomimetic nanoparticles and carrier-free nanomaterials.

Main Methods:

• Review of scientific literature on nanomedicine applications in cancer therapy.
• Focus on natural (e.g., exosomes) and synthetic (e.g., liposomes) nanocarriers.
• Exploration of functionalization strategies for tumor targeting and biomimetic camouflage.

Main Results:

• Nanomaterials offer advantages such as small size, high drug loading capacity, and targeted delivery capabilities.
• Functionalized nanocarriers, including biomimetic nanoparticles, show significant potential in overcoming conventional treatment limitations.
• Several nanoparticle formulations are progressing through clinical trials, with some liposomal drugs already approved.

Conclusions:

• Nanomedicine, particularly targeted nanocarriers and biomimetic nanoparticles, represents a significant advancement in cancer therapy.
• These innovative approaches offer improved efficacy and specificity compared to traditional treatments.
• Further research into advanced nanocarrier systems, including carrier-free nanomaterials, holds great promise for future cancer treatment strategies.